Is Enact publicly traded?
Yes, Enact Holdings, Inc. is a publicly traded company. Its common stock began trading on The Nasdaq Global Select Market on September 16, 2021, under the ticker symbol "ACT".
Related FAQs
Adaptive Biotechnologies generates revenue primarily through a diversified portfolio of diagnostic products, collaborations, and services.
Evaluating whether Enact Holdings (ACT) represents a favorable equity purchase involves analyzing its financial performance within the private mortgage insurance sector, interest rate sensitivities, and housing market dynamics.
Yes, Enact Holdings, Inc. is a wholly owned operating subsidiary of Genworth Financial, Inc.. While Enact has its own independent branding and operates as a publicly traded company, it remains structurally part of the Genworth group of companies.